95
Views
43
CrossRef citations to date
0
Altmetric
Original Research

Patients’ compliance with different administration routes for allergen immunotherapy in Germany

, , &
Pages 1475-1481 | Published online: 24 Oct 2014

References

  • World Allergy OrganizationWAO White Book on Allergy1 edMilwaukeeWorld Allergy Organization2011
  • BousquetJKhaltaevNCruzAAAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)Allergy200863816018331513
  • AkdisCAAkdisMMechanisms of allergen-specific immunotherapyJ Allergy Clin Immunol2011127182721211639
  • BrehlerRKlimekLKoppMVVirchowJCSpecific immunotherapy. Indication and mode of actionDtsch Ärztebl Int201311014815923533561
  • Global Initiative for Asthma (GINA)Global strategy for asthma management and prevention 2014Vancouver, WAGlobal Initiative for Asthma (GINA)2014 Available from: http://www.ginasthma.org/documents/4Accessed October 2, 2014
  • MatricardiPMKunaPPanettaVWahnUNarkusASubcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analysesJ Allergy Clin Immunol201112879179921620452
  • European Medicines Agency CHMP/EWP/18504/2006Guideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic DiseasesEuropean Medicines Agency (EMEA). Committee for Medicinal Products for Human Use (CHMP)2008 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003605.pdfAccessed October 16, 2014
  • CorriganCJKettnerJDoemerCCromwellONarkusAEfficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoidAllergy20056080180715876311
  • WilliamsAHenzgenMRajakulasingamKAdditional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitisEur Ann Allergy Clin Immunol20073912312517523386
  • ZielenSKardosPMadoniniESteroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trialJ Allergy Clin Immunol201012694294920624650
  • KunaPKaczmarekJKupczykMEfficacy and safety of immunotherapy for allergies to Alternaria alternata in childrenJ Allergy Clin Immunol201112750250821281874
  • EngPABorer-ReinholdMHeijnenIAFMGnehmHPETwelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhoodAllergy20066119820116409196
  • DominicusR3-years’ long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adultsEur Ann Allergy Clin Immunol20124413514022905596
  • JacobsenLNiggemannBDreborgSSpecific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT studyAllergy20076294394817620073
  • Alvarez-CuestaEBousquetJCanonicaGWDurhamSRMallingHJValovirtaEStandards for practical allergen-specific immunotherapyAllergy20066112016930249
  • ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
  • European Medicines AgencyICH Topic E 11, Clinical investigation of medicinal products in the paediatric populationLondonEuropean Medicines Agency2001 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002926.pdfAccessed October 2, 2014
  • European Medicines AgencyEMA/PDCO standard pediatric investigation plan for allergen products for specific immunotherapy – Revision 3LondonEuropean Medicines Agency2013 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500015814.pdfAccessed October 2, 2014
  • BousquetJDemolyPCompliance and convenience to immunotherapyArb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M200996289295
  • KoberleinJKotheACSchaffertCDeterminants of patient compliance in allergic rhinoconjunctivitisCurr Opin Allergy Clin Immunol20111119219921467925
  • PassalacquaGBaiardiniISennaGCanonicaGWAdherence to pharmacological treatment and specific immunotherapy in allergic rhinitisClin Exp Allergy201343222823278877
  • GiovanniniMBraccioniFSellaGComparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years studyEur Ann Allergy Clin Immunol200537697115859367
  • Des RochesAParadisLKnaniJImmunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessationAllergy1996514304338837669
  • KettnerJMusslerSHäfnerDNarkusAConsiderable 6 years post treatment long-term effect of pre-seasonal subcutaneous specific immunotherapy (SCIT) with a high-dose hypoallergenic grass pollen preparationAllergy201166suppl 94S296
  • PajnoGBBarberioGDe LucaFMorabitoLParmianiSPrevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up studyClin Exp Allergy2001311392139711591189
  • DiMatteoMRHaskardKBWilliamsSLHealth beliefs, disease severity, and patient adherence: a meta-analysisMed Care20074552152817515779
  • DemolyPDidierAMathelier-FusadePPhysician and patient survey of allergic rhinitis in France: perceptions on prevalence, severity of symptoms, care management and specific immunotherapyAllergy2008631008101418691304
  • ChivatoTDahlRde MonchyJValovirtaEJacobsenLJarishRAllergy: living and learning: level of knowledge (causes and medication) and primary sources of advice and informationAllergy200962suppl 83S89
  • KalpakliogluAFKalkanIKAkcayA(Un) Awareness of allergyWorld Allergy Organ J2011417017823268435
  • RyanDvan WeelCBousquetJPrimary care: the cornerstone of diagnosis of allergic rhinitisAllergy20086398198918691300
  • BiermannJMerkHFWehrmannWKlimekLWasemJAllergic disorders of the respiratory tract – findings from a large patient sample in the German statutory health insurance systemAllergo J201322366373
  • SieberJDe GeestSShah-HosseiniKMösgesRMedication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal ratesCurr Med Res Opin20112785586121323505
  • IncorvaiaCMauroMRidoloEPatient’s compliance with allergen immunotherapyPatient Prefer Adherence2008224725119920970
  • KielMARoderEGerth van WijkRAlMJHopWCRutten-van MolkenMPReal-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapyJ Allergy Clin Immunol201313235336023651609
  • AschemannUSchultePHeckerHExamination of the compliance of a user-friendly allergoid [German]Allergo J201019suppl 1S63
  • SennaGLombardiCCanonicaGWPassalacquaGHow adherent to sublingual immunotherapy prescriptions are patients? The manufacturers’ viewpointJ Allergy Clin Immunol201012666866920816199
  • VitaDCaminitiLRuggeriPPajnoGBSublingual immunotherapy: adherence based on timing and monitoring control visitsAllergy20106566866919845569
  • TworekDBochenska-MarciniakMKuprys-LipinskaIKupczykMKunaPPerennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitisAm J Rhinol Allergy20132730430823636036
  • DistlerAMeijermanAKleinjansHASafety and clinical efficacy of an allergoid depot preparation in children and adolescents in daily practiceAllergy201065suppl 92S574
  • HorneRWeinmanJBarberNElliottRMorganMConcordance, Adherence and Compliance in Medicine Taking: Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO)2005 Available from http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0007/81394/ES-08-1412-076.pdf
  • BrozekJLAklEAAlonso-CoelloPGrading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventionsAllergy200964566967719210357